Labcorp has announced plans to build a new, purpose-built central laboratory services facility in Brownsburg, Indiana, expanding its Indianapolis-area footprint by 40 percent. The new campus will consolidate central laboratory services, diagnostics, kit production, and bioanalytical operations into a single site designed for higher throughput, automation, and long-term scalability.
For lab managers overseeing high-volume testing, clinical trial support, or centralized laboratory operations, the announcement signals how large laboratory organizations are investing in facility design and infrastructure to manage rising workloads, increasingly complex trial protocols, and the operational demands of global studies. The project offers a concrete example of how capacity planning, automation readiness, and integrated workflows are shaping next-generation central labs.
Labcorp central laboratory services expansion in Indiana
The new Brownsburg facility will transition operations from Labcorp’s current Indianapolis site while expanding overall capacity for central laboratory services. The 50-acre campus will include more than 500,000 square feet of advanced laboratory and production space.
The expanded site will house central laboratory services testing, kit production operations, bioanalytical services, and the Indianapolis diagnostics branch. Consolidating these functions allows Labcorp to streamline workflows, improve coordination between laboratory teams, and support higher testing volumes associated with global clinical trial programs.
“This expansion marks an exciting new chapter for Labcorp’s Central Laboratories Services,” said Megan Bailey, EVP and president of central laboratory services and international at Labcorp. “We’re investing in capabilities and resources to advance science, drive innovation and scale our operations to meet customer demand—ultimately enabling us to transform lab and clinical trial services by delivering more integrated, connected experiences for sponsors, sites and patients.”
Automation and infrastructure supporting central laboratory services
The Brownsburg facility is designed to support automation, data analytics, and smart laboratory technologies. In central laboratory services environments, automation commonly includes high-throughput sample handling, automated aliquoting, integrated analytical platforms, and digital systems that track samples and results across the testing lifecycle.
For lab managers, this expansion illustrates how large central labs are designing facilities to scale without increasing manual labor in proportion. Purpose-built infrastructure supports consistent turnaround times, improved traceability, and standardized processes across complex clinical trial laboratory operations.
Central laboratory services and global clinical trial operations
Over the past five years, Labcorp's central laboratory services teams have supported more than 5,000 clinical trials involving patients in more than 100 countries. These efforts are supported by globally integrated laboratories located in Indianapolis, Geneva, Singapore, Shanghai, and Kawagoe City.
The new Indiana facility builds on this model by expanding capacity for centralized testing and data management. For laboratory professionals overseeing clinical trial laboratory operations, the announcement reinforces the role of central laboratory services in enabling multinational studies that require standardized assays, centralized quality oversight, and coordinated data reporting.
Construction is scheduled to begin in the second half of 2026, with completion targeted for early 2030.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
